Trademark: 79151519
Word
PANPHARMA
Status
Dead
Status Code
709
Status Date
Friday, February 4, 2022
Serial Number
79151519
Registration Number
4774728
Registration Date
Tuesday, July 21, 2015
Mark Type
5000
Filing Date
Monday, May 19, 2014
Published for Opposition
Tuesday, May 5, 2015
Cancellation Date
Friday, February 4, 2022

Trademark Owner History
PANPHARMA, Société anonyme - Original Registrant

Classifications
5 Pharmaceutical preparations for the treatment of allergies, diseases related to the central nervous system, immune system diseases, autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondilitis, obesity, diabetes, dyslipemia, brain diseases, locomotor disorders of the central nervous system, break down, multiple sclerosis, thrombosis and cancer, cardiovascular diseases, respiratory system diseases, digestive system diseases, haematological system and skeletal system diseases, psychiatric disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, bronchial disorders, asthma, sinusitis, flu-like states, feverish aches, growth and mineralization disorders, veinolimphatic insufficiency and disorders, capillary fragility disorders, acute haemorroidal episodes, infectious conditions, travel sickness, healing of wounds and burns, sleep disorders, nausea and vomiting, constipation, diarrheas, intestinal disorders, nervousness, stress, hysteria, fears, anxiety and temporary tiredness, neurotonic conditions, gout, cold, rhinitis, cough, influenzas, rhinopharyngitis, sore throats, tracheitis, laryngitis and bacterial and non-bacterial anginas, hoarseness, kicks, lumps and contusions, eczema, cholesterol, degenerations, cutaneous and mucuous disorders, physical and psychic asthenia, menopause, menstruation-related disorders, allergic disorders, gynaecological diseases, rheumatic diseases, urological diseases, gastro-enterological diseases, ophtalmological diseases, dermatological diseases, genital diseases, endocrine diseases, intestinal diseases, blood-related diseases, diseases related to internal medicine, circulatory disorders, muscular disorders, nephropathy, pulmonary embolism, hypertension, atherothrombosis, arrythmia, hearing failure, epilepsy, schizophrenia, neurotic and psychosomatic disorders, hyperplasia, prostate, toxoplasmosis, malaria, malignant and benign tumors, hypercalcemia, hyperuremia, tuberculosis, whooping cough, diphtheria, poliomyelitis, rabies, allergic reactions, metabolic disorder, and control of allergic reactions or metabolic disorders; pharmaceutical preparations for smoking cessation, pharmaceutical sedatives, tranquilizers, depuratives for the body; vitamin, mineral supplements and vaccines for use on domestic animals and livestock for veterinary purposes; dietetic foods, namely, crackers, cakes, soup, meal replacement bars, fruit and vegetable granules adapted for medical use; pesticides, namely, preparations for destroying vermin within the province of the pharmaceutical sector
PAN PHARMA
Color is not claimed as a feature of the mark.

Trademark Events
Nov 17, 2023
New Representative At Ib Received
Nov 13, 2022
Total Invalidation Processed By The Ib
Oct 14, 2022
Total Invalidation Of Reg Ext Protection Sent To Ib
Oct 14, 2022
Invalidation Processed
Oct 4, 2022
Total Invalidation Of Reg Ext Protection Created
Feb 4, 2022
Cancelled Section 71
Dec 2, 2021
International Registration Renewed
Feb 27, 2021
New Representative At Ib Received
Jul 21, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Feb 5, 2016
Final Decision Transaction Processed By Ib
Dec 10, 2015
Generic Madrid Transaction Sent To Ib
Dec 10, 2015
Generic Madrid Transaction Created
Oct 21, 2015
Final Disposition Notice Created, To Be Sent To Ib
Jul 21, 2015
Registered-Principal Register
May 5, 2015
Official Gazette Publication Confirmation E-Mailed
May 5, 2015
Published For Opposition
May 2, 2015
Notification Processed By Ib
Apr 15, 2015
Notification Of Possible Opposition Sent To Ib
Apr 15, 2015
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 15, 2015
Notification Of Notice Of Publication E-Mailed
Mar 28, 2015
Law Office Publication Review Completed
Mar 23, 2015
Assigned To Lie
Mar 4, 2015
Approved For Pub - Principal Register
Mar 3, 2015
Teas Change Of Correspondence Received
Mar 3, 2015
Teas/Email Correspondence Entered
Mar 3, 2015
Correspondence Received In Law Office
Mar 3, 2015
Teas Response To Office Action Received
Sep 25, 2014
Refusal Processed By Ib
Sep 6, 2014
Application Filing Receipt Mailed
Sep 5, 2014
Non-Final Action Mailed - Refusal Sent To Ib
Sep 5, 2014
Refusal Processed By Mpu
Sep 5, 2014
Non-Final Action (Ib Refusal) Prepared For Review
Sep 4, 2014
Non-Final Action Written
Sep 3, 2014
Assigned To Examiner
Sep 2, 2014
New Application Office Supplied Data Entered
Aug 28, 2014
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24